64th ASH Annual Meeting and Exposition: 901. Health Services and Quality—Non-Malignant Conditions: Better, Faster, Stronger: Innovations in Care Delivery, Care Cost, and Healthcare Teams in Classical Hematology

Symposia: Health Services and Quality—Non-Malignant Conditions Oral and Poster Abstracts
Oral

Bleeding and Clotting, bleeding disorders, Sickle Cell Disease, Research, autoimmune disorders, clinical trials, adult, Clinical Practice (Health Services and Quality), Workforce, Clinical Research, health outcomes research, Hemoglobinopathies, Diseases, thrombocytopenias, Immune Disorders, patient-reported outcomes, Therapies, Study Population, Human

295-296 (Ernest N. Morial Convention Center)

Moderators:

Jori E. May, MD, University of Alabama at Birmingham and Jacob Cogan, MD, University of Minnesota

Disclosures:

No relevant conflicts of interest to declare.

There remains significant opportunity to improve the delivery of high quality care for patients with classical hematologic disorders. First, authors will present innovations in care delivery and health care teams, including the use of electronic consultation, incorporation of advanced practice providers, and developing remote mentorships networks for trainees with interest in classical hematology. Next, authors will present care innovation and/or cost effectiveness analysis in the care of patients with three disorders: heavy menstrual bleeding, sickle cell disease, and thrombotic thrombocytopenic purpura (TTP).

4:30 PM

667

The Performance of Electronic Consultation in Non-Malignant Hematology in a Fee-for-Service Care Delivery Model

Hyndavi Kandala, MD¹, Rita D Paschal, MD¹, Radhika Gangaraju, MD¹, Kaci B Weaver, CRNP¹^*, Kelsey Mitchell, MPH, RN²^*, Andrew Land, MD³^*, Eric L. Wallace, M.D.⁴^* and Jori E. May, MD¹

¹Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
²Clinical Informatics, University of Alabama at Birmingham, Birmingham, AL
³Division of General Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁴Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

4:45 PM

668

Advanced Practice Providers (APPs) in Hematology: Work Practices, Interactions with Physicians, and Opportunities for Collaboration within the American Society of Hematology (ASH)

Leah E Masselink, PhD¹^*, Clese E Erikson, MPAff¹^*, Gina Moses²^*, Faith E. Davies, MD^3,4^*, Azam Farooqui, MD⁵, Peter A. Kouides, MD^6,7, Srikanth Nagalla, MBBS, MS⁸ and Ariela L. Marshall, MD⁹

¹Fitzhugh Mullan Institute for Health Workforce Equity, George Washington University, Washington, DC
²American Society of Hematology, Washington, DC
³NYU Langone Health, Myeloma Research Program, Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
⁴NYU Langone Medical Center, New York, NY
⁵Ironwood Cancer and Research Centers, Chandler, AZ
⁶Department of Medicine, Mary M. Gooley Hemophilia Center, Rochester, NY
⁷University of Rochester, Rochester, NY
⁸Miami Cancer Institute, Miami, FL
⁹Department of Hematology-Oncology, Penn Medicine, Philadelphia, PA

5:00 PM

669

Evaluating the Impact of a Year-Long External Mentorship Pilot Program in Classical Hematology

Zoya Qureshy, MD¹^*, Nathan T. Connell, MD, MPH², Alfred I Lee, MD, PhD³, Allison A. King, MD, PhD, MPH⁴, Martina C Murphy, MD⁵, Erin G Reid, MD, MS⁶ and Soo Park, MD⁷

¹University of California San Diego, San Diego, CA
²Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA
³Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT
⁴Pediatric Hematology/Oncology, Washington University School of Medicine, Clayton, MO
⁵UF Hematology/Oncology, Gainesville, FL
⁶Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁷University of California San Diego, La Jolla, CA

5:15 PM

670

Cost-Effectiveness of Caplacizumab without First-Line Therapeutic Plasma Exchange Vs. Standard-of-Care for Patients with Immune Thrombotic Thrombocytopenic Purpura: Setting Future Clinical Trial Thresholds

Ayesha Butt, MBBS^*, Alfred I Lee, MD, PhD and George Goshua, MD, MSc

Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT

5:30 PM

671

Take Control. Period. –Interactive Patient Education Website Enhances Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Savannah Norman, MD¹, Ying Ling, MD², Meffe Filomena, MD, MSc³^*, Shamshah Aratia⁴^*, Deborah Robertson, MD⁵^*, Aziz Jiwajee⁶^*, Grace Tang, MSc⁷^*, Paula D. James, MD, FRCPC⁸, Jeff Mosko, MD MSc⁹^* and Michelle Sholzberg, MD¹⁰

¹Division of Hematology, Department of Medicine, University of Toronto, Oakville, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Department of Obstetrics and Gynecology, Unity Health Toronto, St. Michael’s Hospital, University of Toronto, Toronto, Canada
⁴St. Michaels Hospital, University of Toronto, Toronto, Canada
⁵Department of Obstetrics and Gynecology, Unity Health Toronto, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada
⁶Division of Hematology/Oncology, Department of Medicine, Unity Health, St. Michaels Hospital, University of Toronto, Toronto, ON, Canada
⁷Division of Hematology/Oncology, Department of Medicine, Unity Health Toronto, St. Michaels Hospital, University of Toronto, Toronto, Canada
⁸Department of Medicine, Queen's University, Kingston, ON, Canada
⁹Division of Gastroenterology, Department of Medicine, Unity Health Toronto St. Michael’s Hospital, University of Toronto, Toronto, Canada
¹⁰St. Michael's Hospital, University of Toronto, Toronto, ON, Canada

5:45 PM

672

Intensive Case Management in an Adult Sickle Cell Medical Home: Annual Effects on Utilization Efficiency Using Community Health Workers

Shirley Johnson, BA, LSW¹^*, Daniel M Sop, MS, BS², Yue May Zhang, MS³^*, Benjamin Jaworowski, BS¹^* and Wally R Smith, MD⁴

¹Virginia Commonwealth University, Richmond, VA
²General Internal Medicine, Virginia Commonwealth University, Richmond, VA
³General internal Medicine, Virginia Commonwealth University, Richmond, VA
⁴Internal Medicine, Virginia Commonwealth University, Richmond, VA

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

901.O3.6 901. Health Services and Quality—Non-Malignant Conditions: Better, Faster, Stronger: Innovations in Care Delivery, Care Cost, and Healthcare Teams in Classical Hematology